BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Buthionine Sulfoximine

A synthetic amino acid that depletes glutathione by irreversibly inhibiting gamma-glutamylcysteine synthetase. Inhibition of this enzyme is a critical step in glutathione biosynthesis. It has been shown to inhibit the proliferative response in human T-lymphocytes and inhibit macrophage activation. (J Biol Chem 1995;270(33):1945-7)

300+ PubMed studies analyzed · Evidence Score: 37.5

Research Domains

Buthionine Sulfoximine has been studied across 18 research domains including 🫁 Liver & Detox, 🔬 Oncology, 🔬 Inflammation, 🫘 Kidney, ⚡ Energy & Fatigue. The primary research focus is 🫁 Liver & Detox with 82% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Buthionine Sulfoximine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Galactitol
2 shared targets
Carbutamide
2 shared targets
Pyrrolidonecarboxylic
2 shared targets
Carduus
2 shared targets
Pyridoxine
2 shared targets
Fomepizole
2 shared targets
pipemidic
2 shared targets
sulfameter
2 shared targets
Fluvastatin
2 shared targets
Tobramycin
2 shared targets
Loading evidence profile...

This evidence profile for Buthionine Sulfoximine is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.